Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
Study NCT ID:
NCT05394012
Status:
UNKNOWN
Last Update Posted:
2022-11-18
First Post:
2022-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
Sponsor:
Walvax Biotechnology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RQ3013-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |